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a b s t r a c t
In contrast to orthoretroviruses, the foamy virus protease is only active as a protease-reverse
transcriptase fusion protein and requires viral RNA for activation. Maturation of foamy viral proteins
seems to be restricted to a single cleavage site in Gag and Pol. We provide evidence that unprocessed Gag
is required for optimal infectivity, which is unique among retroviruses. Analyses of the cleavage site
sequences of the Gag and Pol cleavage sites revealed a high similarity compared to those of Lentiviruses.
We show that positions P2' and P2 are invariant and that Gag and Pol cleavage sites are processed with
similar efﬁciencies. The RNase H domain is essential for protease activity, but can functionally be
substituted by RNase H domains of other retroviruses. Thus, the RNase H domain might be involved in
the stabilization of the protease dimer, while the RT domain is essential for RNA dependent protease
activation.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The foamy viral replication cycle differs in several aspects from
those of orthoretroviruses (for review see (Bodem, 2011; Hütter
et al., 2013b; Lee et al., 2013; Linial, 2007; Löchelt, 2003;
Rethwilm, 2003). For instance the foamy viral Pol protein is
translated from a spliced transcript and not as Gag–Pol precursor
protein (Bodem et al., 1996; Löchelt and Flügel, 1996; Yu et al.,
1996), leading to a Pol precursor consisting of a protease (PR),
reverse transcriptase (RT), RNase H (RH) and integrase (IN)
domain. Thus, Pol is not incorporated as Gag–Pol precursor but
encapsidated via an interaction with the genomic RNA (for review
see Lee et al., 2013, Rethwilm, 2013, Rethwilm and Lindemann,
2013). On the other hand, it has been suggested that an additional
Gag–Pol interaction is required for genome and/or Pol incorpora-
tion (Lee and Linial, 2008). The foamy viral PR seems to be active
as a fusion protein of PR, RT and RH, whereas the PR domain alone
is unable to form active dimers (Hartl et al., 2008). The structure of
the foamy viral PR domain is similar to the PR of the human
immunodeﬁciency virus 1 (HIV-1) except of the unstructured
C-terminal dimer interface (Hartl et al., 2008). We have shown
that dimerization of PRRTRH protein is achieved by a speciﬁc
interaction with the PR activation RNA motif (PARM) encoded by
the genomic RNA (Hartl et al., 2011).
In contrast to HIV-1, foamy virus (FV) Gag and Pol maturation is
limited to a single cleavage site in both proteins. Maturation of Gag
p71 results in a Gag p68 and a p3 peptide. This cleavage event was
shown to be strictly required for infectivity (Baldwin and Linial,
1999; Enssle et al., 1997; Hütter et al., 2013a; Lehmann-Che et al.,
2005). Recently, we have reported inactivation of the Gag p68/p3
cleavage site inhibits reverse transcription at the ﬁrst template
switch (Spannaus et al., 2013). Thus, Gag maturation regulates
reverse transcription. On the other hand it has been shown that p3
is not essential for infectivity (Enssle et al., 1997; Hütter et al.,
2013a; Stenbak and Linial, 2004; Zemba et al., 1998) and that wild-
type FVs contain a mixture of Gag p71/p68 proteins at a ratio of
about 1:4 (Cartellieri et al., 2005). Three additional Gag cleavage
sites, beside the p68/p3 cleavage site, were determined by in vitro
PR assays, but only for the cleavage site at amino acid residue 311
of Gag an in vivo function has been assigned (Lehmann-Che et al.,
2005; Pfrepper et al., 1999). This processing event seems to be
required for disassembly of the Gag lattice (Lehmann-Che et al.,
2005). HIV-1 Gag maturation results in fundamental changes of
the virus structure, since the PR activity is required for formation
of the spherical immature core particle and for condensation of
the viral core during maturation (for review see Sundquist and
Kräusslich 2012). The structural rearrangements of the FV Gag are
less pronounced than those observed during HIV-1 maturation
(Konvalinka et al., 1995; Sundquist and Kräusslich, 2012).
Pol maturation is not strictly required for infectivity (Hütter
et al., 2013a), but viral titers decrease approximately 2 orders of
magnitude after inactivation of the RH/IN cleavage site (Roy and
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Linial, 2007). For Pol processing amino acid residues at positions
P1 and P1' are replaceable by alanine residues without losses of
infectivity, whereas the additional exchanges of residues at posi-
tions P2' and P2 results in impaired Pol processing and a reduction
of virus titers by factor 300 (Roy and Linial, 2007). By determina-
tion of autocatalytic processing products of the Pol protein
expressed in bacteria, two additional PR cleavage sites in Pol were
identiﬁed (Pfrepper et al., 1998). These sites have neither been
veriﬁed in context of recombinant viruses nor cleavage efﬁciencies
in vitro were determined.
The FV Gag and Pol cleavage sites share a high similarity on
amino acid level compared to the HIV-1 PR cleavage site sequences
suggesting a more restricted substrate repertoire of the foamy viral
PR (Enssle et al., 1997) and the exchange of a single amino acid
residue (T624A) within the Gag PR cleavage site results in
impaired maturation in wild-type Prototypic FV (PFV) (Baldwin
and Linial, 1999). In this report, we present a systematically
analysis of the foamy viral cleavage site sequences in cell culture
by glycine-scanning. Furthermore, we show that the RH domain is
required for PR activity, but can be replaced by their Moloney
murine leukemia virus (Mo-MLV) and HIV-1 counterparts.
Results
Viral infectivity is dependent on Gag processing—Pol maturation is
independent of Gag cleavage
To compare maturation efﬁciencies of Gag and Pol and to analyze
the dependency of processing on protein environment we exchanged
the Gag cleavage site with the RH/IN cleavage site of FV Pol (Fig. 1A
and Table 1). In addition, a Gag p71 expression plasmid expressing a
hybrid cleavage site encoded the amino acid residues of Gag at the
positions P4'–P1' and the amino acid residues of IN at P1–P4 was
constructed (p68/IN)(Fig. 1A and Table 1). HEK 293 T cells were
transfected with these gag expression plasmids and with codon-
optimized expression plasmids for env, pol and the gfp encoding viral
genome. After three days the virus supernatant was partially puriﬁed
using size exclusion chromatography and concentrated by ultra-
centrifugation. It has been reported that foamy viral Pol proteins are
secreted in an Env independent way from transfected eukaryotic cells
(Hütter et al., 2013a; Swiersy et al., 2011). The puriﬁcation by size
exclusion using Capto Core700 columns was sufﬁcient to remove non-
particle associated Pol proteins from the supernatant (Supplementary
material Fig. S5). Infectivity was determined and Gag processing was
analyzed in cellular lysates and recombinant viruses by quantitative
Western blotting analyses in independent triplicates (Fig. 1B and C).
Quantitative Western blotting analyses were normalized on wild-type
vector system Gag maturation. Around 50% of the Gag proteins were
processed in the cellular lysates and 42% in the virus particles. These
low Gag cleavage efﬁciencies were due to the low Pol amounts used in
the experiment for a more sensitive detection of small differences in
processing. By the introduction of the Pol RH/IN cleavage site, the Gag
processing in the viral particles and cellular lysates as well as the
infectivity was wild-type like (Fig. 1B–D; Table 1). Maturation of Gag
proteins with the hybrid p68/IN cleavage site in the viral particles was
also unaffected, but processing in cellular lysates and infectivity were
slightly decreased.
To further determine the inﬂuence of strictly conserved resi-
dues within the cleavage site a glycine-scanning exchanging each
amino acid residue of the cleavage site was performed (Fig. 1A and
Table 1). The maturation efﬁciency of Gag was determined by
Western blotting analyses of the cellular lysates and of the
partially puriﬁed recombinant viruses. As expected Pol cleavage
was independent of Gag cleavage efﬁciency (Fig. 1B). The recently
described Gag N621G mutant was almost completely processed,
whereas the infectivity of the virus particles was decreased by
more than one order of magnitude (Fig. 1C and D compare wild-
type and N621G; Table 1) comparable to the p3 deletion in Gag
p68 viruses (Spannaus et al., 2013). In addition to the recently
described amino acid exchanges at position P2' (Gag V620G) also
the exchange at position P2 (Gag V623G) resulted in impaired Gag
maturation comparable to the cleavage site deﬁcient p71ΔCS Gag
(Fig. 1B lanes 6, 9 and 12, 1C and 1D corresponding bars; Table 1).
This suggests a key role of these two valine residues at the P2' and
P2 positions for Gag maturation. Overall, Gag cleavage efﬁciency
Table 1
Amino acid exchanges within the PFV Gag PR cleavage sites.
Cleavage site Amino acid sequencea Infectivity [%] Cleavage efﬁciency Cleavage efﬁciency [%]
p68/p3wt RAVN/TVTQ 100 0.42 100
FV vector systemb p68/p3R618G GAVN/TVTQ 10 0.33 79
p68/p3A619G RGVN/TVTQ 52 0.35 83
p68/p3V620G RAGN/TVTQ o1 0.06 14
p68/p3N621G RAVG/TVTQ 5 0.87 208
p68/p3T622G RAVN/GVTQ 46 0.28 68
p68/p3V623G RAVN/TGTQ o1 0.06 15
p68/p3T624G RAVN/TVGQ 30 0.39 74
p68/p3Q625G RAVN/TVTG 10 0.33 78
p68/p3RH/IN YVVN/CNTK 105 0.47 112
p68/p3p68/IN RAVN/CNTK 72 0.42 99
p68/p3ΔCS GALG/ALGA o1 0.05 11
Proviral plasmidc p68/p3 RAVN/TVAQ 0 0
Proviral plasmidd p68/p3 GAGN/TVTQ 0 0
p68/p3 RAVN/AGAQ 0 0
p68/p3 RAVN/TVTL-HIVp6 10 þ
p68/p3 REVN/TVTQ 100 ND
p68/p3 RKVN/TVTQ 100 ND
Proviral plasmide p33/p5I310E QHER/SVTG 0 0
þ , Cleaved, but efﬁciency not quantiﬁed.
ND, not determined.
a Exchanged amino acid residues are depicted in gray.
b This study.
c Baldwin and Linial (1999).
d Enssle et al. (1997).
e Lehmann-Che et al. (2005).
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correlates with viral infectivity (Fig. 1B–D and Table 1), since an
impaired Gag cleavage results in a reduction of the virus titers by
more than four orders of magnitude and indicates that Gag
maturation is strictly required for infectivity.
Small amounts of unprocessed viral Gag p71 seem to be important for
optimal infectivity of Gag p68 containing FV particles
Recently, we have shown that Gag processing is required for the
ﬁrst template switch during reverse transcription (Spannaus et al.,
2013). To determine the correlation of Gag processing and infectivity,
cells were transfectedwith the FV vector system, but Gag was replaced
by Gag p71ΔCS and p68 (Fig. 2A) at different ratios. Gag maturation in
cellular lysates and the partially puriﬁed and concentrated viruses
were analyzed by quantitative Western blotting and normalized on
wild-type PFV Gag maturation as described above (Fig. 2B and C). The
Gag processing in the cellular lysates was similar to the maturation in
the virus particles. First, we conﬁrmed that transfection of HEK 293 T
cells with different p71ΔCS/p68 ratios resulted in a similar relative Gag
p71/p68 amounts (Fig. 2B and C), then p71/p68 ratios were calculated
and compared to wild-type Gag processing. Infected cells contained
83% mature p68 Gag and in wild-type viruses 85% of processed Gag
was measured (Fig. 2B and C lane/bar 1). Viruses with only unpro-
cessed p71 Gag were non-infectious, while Gag p68 viruses showed
a decrease of infectivity of approximately one order of magnitude
(Fig. 2D). Recombinant viruses with p71/p68 Gag ratios similar to
wild-type Gag maturation showed the highest infectivity. On the other
hand, viral titers of the wild-type vector system were not reached
by any ratio of p71ΔCS and p68. These results underline that Gag
processing is strictly required for infectivity. Nevertheless, in contrast
to orthoretroviruses small amounts of unprocessed Gag p71 seem to
be important for optimal viral infectivity.
Introduction of the Hybrid Gag p68/IN cleavage sites in Pol results in a
reduced Pol cleavage efﬁciency
In order to analyze the Pol processing we exchanged in the
context of the codon-optimized pol the RH/IN cleavage sites with
the p68/p3 or with the hybrid p68/IN cleavage site sequences by
site directed mutation (Fig. 3A and Table 2). The resulting plasmids
were named Polp68/p3 and Polp68/IN. In addition, we inactivated
the cleavage site by mutating the coding sequence, leading to the
PolΔCS plasmid (Fig. 3A and Table 2). HEK 293 T cells were
transfected with vector system, recombinant viruses were con-
centrated and analyzed by Western blotting for Gag and Pol
processing. The processing efﬁciencies of the Pol proteins in the
cellular lysates (wild-type, 45% processed Pol) and in the viral
particles (wild-type, 76% processed Pol) were determined by
quantitative Western blotting and normalized on the Pol matura-
tion of the wild-type vector system. The cleavage efﬁciency in the
viral particles of Pol encoding a p68/p3 cleavage site was compar-
able to the wild-type Pol, but the infectivity of the recombinant
viruses was signiﬁcantly reduced (Fig. 3B lanes 1–2, 3C and 3D
corresponding bars; Table 2). Introduction of the p68/IN hybrid
cleavage site strongly impaired cleavage in both the cellular lysates
and virus particles (Fig. 3B and C; Table 2) and resulted in a
reduction of infectivity by one order of magnitude (Fig. 3D
compare bars 1 and 3). The loss of infectivity is comparable to
recombinant viruses with RH/IN cleavage site deletion (PolΔCS)
(Fig. 3A–D and Table 2). Overall, Pol maturation is more reduced in
cellular lysates compared to the processing efﬁciencies in the
recombinant viruses. This might be due to a higher local Pol
concentration in viral particles. Similar cleavage efﬁciencies of the
p68/p3 and the RH/IN cleavage sites in the context of the Gag and
Pol proteins were found leading to the conclusion that in contrast
to HIV-1 the time-point of Gag and Pol maturation is not regulated
by the cleavage efﬁciency.
Sequence comparison of the wild-type Pol and the hybrid p68/
IN cleavage sites revealed differences only at positions P4' and P3'
(Fig. 3A and Table 2). To further investigate inﬂuences of these
exchanges we analyzed the single amino acid substitutions Pol
Y748R and Pol V749A by constructing the Pol Y748R and Pol
V749A expression plasmids (Fig. 3A and Table 2). In comparison to
wild-type Pol the maturation of Pol Y748R and Pol V749A was
impaired, while cleavage efﬁciencies of both Pol cleavage sites
variants were found to be signiﬁcantly higher than with the p68/
IN hybrid cleavage site (Fig. 3B and C; Table 2). This indicates an
additive effect on the recovery of infectivity and cleavage efﬁcien-
cies of these two amino acid residue exchanges. The infectivity of
Table 2
Amino acid exchanges within the PFV Pol PR cleavage sites
Cleavage site Amino acid sequencea Infectivity [%] Cleavage efﬁciency Cleavage efﬁciency [%]
RH/INwt YVVN/CNTK 100 0.76 100
FV vector systemb RH/INY748G GVVN/CNTK 12 0.62 83
RH/INV749G YGVN/CNTK 93 0.45 60
RH/INV750G YVGN/CNTK 11 0.08 11
RH/INN751G YVVG/CNTK 104 0.60 81
RH/INC752G YVVN/GNTK 70 0.41 55
RH/INN753G YVVN/CGTK 15 0.17 22
RH/INT754G YVVN/CNGK 64 0.47 63
RH/INK755G YVVN/CNTG 92 0.75 100
RH/INp68/p3 RAVN/TVTQ 20 0.74 97
RH/INp68/IN RAVN/CNTK 12 0.18 24
RH/INY748R RVVN/CNTK 17 0.51 66
RH/INV749A YAVN/CNTK 36 0.62 80
RH/INΔCS GALG/ALGA 10 0.06 8
Proviral plasmidc RH/IN YVVA/ANTK 63 þ
RH/IN YVGH/WNTK 38 0
RH/IN YVAA/AATK 19 0
RH/IN YAAA/AAAK 7 0
RH/IN AAAA/AAAA o1 0
þ , Cleaved, but efﬁciency not quantiﬁed.
a Exchanged amino acid residues are depicted in gray
b This study.
c Roy and Linial (2007).
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the particles containing the Pol variants with exchanges in
cleavage sites correlates with maturation except of the Pol p68/
p3 proteins (Fig. 3C and D; Table 2).
To further analyze the amino acid composition of Pol cleavage
sites a glycine-scanning was performed (Fig. 4). Pol maturation
correlates with infectivity (compare Fig. 4B–D and Table 2). Similar
to the results obtained with Gag the exchange of the amino acid
residue from valine to glycine in position P2' (V750G) inhibited
processing comparable to cleavage site deﬁcient PolΔCS construct
(Fig. 4B–D, lanes/bars 4 and 10; Table 2). The infectivity of the viral
particles with V750G exchanges was reduced by one order of
magnitude. The exchange in the position P2 (N753G) resulted in a
less pronounced drop in cleavage efﬁciency and viral infectivity
(Fig. 4B–D lanes/bars 7 and 10; Table 2). The exchange of amino
acid residue Y748G (P4') resulted in a slightly reduced Pol
cleavage, but in a drop of viral infectivity by one order of
magnitude (Fig. 4B–D lanes/bars 1 and 2; Table 2). As P4' is part
of C-terminal RH α-helix an exchange of the amino acid might
have impaired RH activity (Leo et al., 2012a; Leo et al., 2012b).
The results of the glycine-scanning experiments indicate a key
role of the asparagine at position P2 and especially the valine at
position P2' for Pol processing (Fig. 4 and Table 2). These ﬁndings
are consistent with the results obtained from the glycine-scanning
at the Gag cleavage site (Fig. 1). Other amino acid residues
contribute to the cleavage site speciﬁcity as demonstrated by the
analyses of the Pol p68/IN and Y748R proteins (Fig. 3 and Table 2).
The conclusion of the glycine-scanning in Gag and Pol is that in
both PR cleavage sites the amino acid residues at positions P4', P1'
and P4 could be substituted by glycine without signiﬁcant reduc-
tion of processing efﬁciency (Figs. 1 and 4; Tables 1 and 2)
indicating a certain ﬂexibility at these cleavage site positions.
The substitutions at the positions P3', P1 and P3 resulted in a
reduction of processing efﬁciency in the context of the Pol
proteins, whereas in the context of the Gag proteins the inﬂuence
of these amino acid exchanges were less pronounced.
The RH domain and not the RT domain is essential for PR activity—
The RT domain is required for the genome dependent PR activation
Recently, we have shown that the activation of PR requires viral
RNA containing the PARM element and PRRTRH protein (Hartl
et al., 2011), whereas the IN domain was not essential for Gag
processing (Spannaus et al., 2012). To further extend these results,
we sought to determine the role of the RH domain for PR activity.
The RNase H coding region encompasses 166 amino acid residues.
Codon optimized PRRTRH plasmids lacking either only the last
carboxyl terminal 78 amino acid residues (PRRTRHΔ78C) or the
complete RH domain were constructed. These plasmids were used
in combination with the complete FV vector system. To ensure
exclusion of non-particle associated Pol proteins viruses were
puriﬁed with a HiTrap Capto Core 700 size exclusion column for
virus puriﬁcation. To analyze the RNA dependence experiments
with or without the gfp encoding vector genome pMD9 were
performed. The infectivity of all viruses without IN domain with
vector genome was reduced by three orders of magnitude
(Fig. 5D), whereas viruses without genome and the untransfected
negative control were non-infectious. Both Gag processing and Pol
encapsidation were analyzed by Western blotting (Fig. 5 and
Supplementary Fig. S2). The PRRTRHΔ78C and the PRRT proteins
were not able to cleave Gag in recombinant viruses with compar-
able efﬁciencies as the PRRTRH protein (Fig. 5B compare lanes
3 with 5–8 and 5C corresponding bars). Thus, we concluded that
the RH domain is essential for PR activity. Next we analyzed
whether the RT domain is essential for Gag processing. A PRRH
plasmid (without the RT domain) was constructed (Fig. 5A) and
analyzed in context of the FV vector system. The PRRH protein was
encapsidated independent of viral RNA in viral particles and
surprisingly cellular and viral Gag proteins were processed with
a higher efﬁciency as the RH truncations. The difference of Gag
maturation by PPRH and PRRT in recombinant viruses were found
to be signiﬁcant (p-valueo0.05) indicating that the RH domain is
sufﬁcient to promote PR activation (Fig. 5B lanes 9–10 and 5C
corresponding bars). The analysis of cellular Pol amounts revealed
that the expression of all shortened Pol proteins were almost
similar to the wild-type (factor r2) (Fig. 5B and Supplementary
Fig. S1). To further investigate the incorporation of the different
Pol truncations the Gag/Pol ratios were calculated in triplicates
and were normalized on wild-type vector system (Supplementary
Table S1). The incorporation of the different Pol proteins and the
wild-type Pol was genome independent. Interestingly the Gag/Pol
ratios of viruses without genome were up to 4 fold reduced.
Possibly due to the overexpression of the viral proteins in the
cellular lysates the interaction of the Gag and Pol proteins might
be sufﬁcient for Pol incorporation as suggested before (Lee and
Linial, 2008). Overall the Gag/Pol ratios with genome vary
between 1 (wild-type) and 2.7 (PRRH). Based on the fact that both
proteins were able to cleave Gag proteins we conclude that the Pol
content in all viruses is sufﬁcient for processing analysis. The Gag
maturation in the cellular lysates is genome independent, whereas
the Gag processing efﬁciencies in the viral particles containing
wild-type Pol or PRRTRH are signiﬁcantly reduced without the
vector genome despite of their higher Pol content (Fig. 5B lanes
1–4 and 5C corresponding bars; Supplementary Table 1). Thus,
PRRH proteins support Gag processing in genome independent
way indicating a stabilization of the PR dimers by the RH domains,
since PR activity has never been observed under physiological
conditions using the PR domain alone (Flügel personal commu-
nication, (Hartl et al., 2011; Hartl et al., 2010; Hartl et al., 2008)).
The RT domain seems to be required for the genome dependent
activation of the viral PR.
The HIV-1 and Mo-MLV RH domains support PR activation
Based on these results we analyzed whether the RH domain of
Mo-MLV or HIV-1 could functionally replace the FV RH domain in
PR activation. The foamy viral RH domains of the full length Pol
and the PRRTRH expression constructs were replaced by the HIV-1
and the Mo-MLV RH domains in context of the codon optimized FV
pol using PCR based cloning strategies (Fig. 6A). Cells were
transfected with the resulting PRRT MLVRH, PRRT HIVRH, Pol
MLVRH or Pol HIVRH expression plasmids and the FV vector
system or without vector genome. Similar to Pol truncations the
infectivity of all viruses without IN domain is reduced by three
orders in magnitude (Fig. 5D), whereas viruses without genome
and the untransfected negative control were found to be non-
infectious. The Gag processing and Pol encapsidation were ana-
lyzed by Western blotting using Gag or RT monoclonal antibodies
(Fig. 6B lanes 3–10). The incorporation of all Pol derived proteins
encoding heterologous RH domains was reduced in comparison to
wild-type (Supplementary Fig. S4). The Gag/Pol ratios for the virus
particles were calculated as described above (Supplementary Table
S1). The PRRT MLVRH and HIVRH led to slightly reduced Gag
processing in comparison to the FV PRRTRH (compare Fig. 5B lanes
3–4 and 5C corresponding bars with Fig. 6B lanes 3–6 and 6C
corresponding bars) showing that the RH domains of Mo-MLV and
HIV-1 support activation of the FV PR almost similar to the foamy
viral RH domain. The full-length Mo-MLV RH and HIV-1 RH Pol
proteins resulted also in only slightly reduced cleavage efﬁciencies
of the Gag proteins in comparison to the wild-type (Fig. 6B lanes 1,
2, 7–10 and 6C corresponding bars), but resulting recombinant
viruses showed a reduced infectivity of three orders of magnitude
(Fig. 6D). These results provide evidence that the RH domain is
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essential for PR activity. In contrast to the wild type Pol and the Pol
MLVRH the Pol HIVRH proteins were not cleaved at the RH/IN
protease cleavage site. The PR activities of all viruses were genome
dependent while Pol incorporation was not. Gag processing
efﬁciencies in the cellular lysates were genome independent as
already observed above (Fig. 6B–C). These ﬁndings together with
the results presented above suggest the requirement of RT and RH
domain for a genome dependent activation of the foamy viral PR.
Discussion
In this study we have characterized the amino acid residue
sequence of the Pol RH/IN and the Gag p68/p3 PR cleavage sites
required for efﬁcient maturation and infectivity (Tables 1 and 2).
This and previous cell culture based analyses of foamy viral
cleavage sites provide evidence that the valine amino acid residue
at position P2' is essential for cleavage, since exchanges to glycine
or alanine residues resulted in non-cleavable sites (Enssle et al.,
1997; Lehmann-Che et al., 2005; Roy and Linial, 2007). This
suggests the requirement of larger amino acid residues than
glycine and alanine at these positions. The importance of the
valine residue at position P2' was underlined by the peptide
cleavage assay of the predicted PR/RT cleavage site with glutamic
acid at this position (Table 3) (Pfrepper et al., 1998). Even
prolonged over-night incubation resulted in only small amounts
of cleavage products (Fenyöfalvi et al., 1999). An exception to this
rule was found in the PR in vitro assays with the Ty1 derived RT/IN
cleavage site, where isoleucine replaced the valine residue at
position P2' (Table 2 and (Fenyöfalvi et al., 1999). The analyzed
peptide was cleaved to 67% in 2 h showing that the replacement of
valine by isoleucine leads to a functional cleavage site.
Table 3
Cleavable peptides analyzed by in vitro PFV PR assays
Cleavage site Amino acid sequence a Cleavage efﬁciency [%]
PR assaysa p68/p3 RAVN/TVTQ 100
p33/p5 QHIR/SVTG 15
p3.5/p1.5 DGVF/PVTT ND
p1.5/p29 RIIN/AILG 36
PR assaysb, c RH/IN YVVN/CNTK 100
PR/RT HWEN/QVGH þ
RT/RH EGVF/YTDG þ
PR assaysc Ty1 PR/IN PTIN/NVHT 7
Ty1 IN/RT HLIA/AVKA 67
Ty3 RT/IN RAVY/TITP 33
Ty3 RT/IN NVVS/TIQS þ
Ty3 RT/IN NVVS/TIQS þ
þ Cleaved, but efﬁciency not quantiﬁed.
ND, not determined.
a Pfrepper et al. (1999).
b Pfrepper et al. (1998).
c Fenyöfalvi et al. (1999).
Fig. 1. FV infectivity is correlated to Gag maturation. (A) Schema of Gag p68/p3 cleavage sites used in this study. Exchanges of the cleavage site residues are indicated in gray.
(B) Western blotting analysis of concentrated recombinant viruses and cellular lysates with monoclonal anti-Gag, polyclonal anti-IN, or anti-GAPDH immune sera. In
addition, to the exchange of the Gag cleavage site a glycine-scanning was performed from the P4' to the P4 position of the Gag cleavage site. Positions of the size markers are
indicated. (C) Percentage of processed Gag calculated by quantiﬁcation of the Gag p71 and p68 bands in three independent assays (p68/(p68þp71)) in cellular (gray bars)
and viral lysates (black bars). Quantitative Western blots were normalized on wild-type vector system Gag maturation (in cellular lysate 50% and in viral lysate 42%). Error
bars indicate the standard deviation of the independent triplicate quantiﬁcations. The signiﬁcances of differences in processing compared to wild-type maturation
efﬁciencies determined by the paired two-sample t-test were marked with one (p-value o0.05) or two black asterisks (p-value o0.01) above the bars. (D) Viral titers were
determined on BHK-21 cells by serial dilutions. Error bars indicate the standard deviation of three independent triplicate samples. The signiﬁcances of differences in
infectivity compared to wild-type vector system were determined and indicated as described above.
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At the cleavage site position P2 a valine (Gag) or asparagine
(Pol) residue were shown to be essential for cleavage. In vitro
PR assays showed that in position P2 in addition to asparagine
or valine, isoleucine and threonine support peptide cleavage
(Fenyöfalvi et al., 1999). The latter is located in the predicted RT/
RH cleavage site at position P2 (Pfrepper et al., 1998). Since
structures of threonine and of valine are similar one can assume
that the processing efﬁciency of the RT/RH cleavage site is similar
to the p68/p3 cleavage site, but processing of the RT/RH peptide is
limited in comparison to the RH/IN peptide with the less similar
asparagine residue in position P2 (Fenyöfalvi et al., 1999). In all
cleavable sites and peptides analyzed so far, a small or a nucleo-
philic amino acid was located in position P1 (Tables 1–3) (Baldwin
and Linial, 1999; Fenyöfalvi et al., 1999; Pfrepper et al., 1999;
Pfrepper et al., 1998). In four peptides analyzed for cleavage, either
a proline, glutamine, tyrosine, or an asparagine residue were
introduced in P1 and the processing efﬁciencies were found to
be low (Fenyöfalvi et al., 1999; Pfrepper et al., 1999) (Table 3). To
determine if these four substitutions in P1 inhibit maturation the
single amino acid substitutions remains open, but P1 seems to be
restricted to small or nucleophilic amino acids. The amino acid
threonine is conserved at position P3 in the context of the primate
Gag and Pol proteins. This observation suggests a requirement of
threonine in position P3, but in the peptide in vitro protease assays
the position seems to be more variable, since peptides encoding
the amino acid residues histidine, lysine, glutamine, glycine,
aspartic acid or leucine at P3 were processed in vitro (Fenyöfalvi
et al., 1999; Pfrepper et al., 1999; Pfrepper et al., 1998). On the
other hand, all these peptides encoded additional amino acid
exchanges, which might have been inﬂuenced the result. The
other positions within the foamy viral cleavage sites seem to be
completely variable, since a wide amino acid repertoire was
published for P4', P3', P1', and P4 (Tables 1–3). Summing-up, in
contrast to other retroviruses at least positions P2' and P2 are
invariant in primate and bovine FVs, showing a restricted cleavage
site repertoire.
Here, we have shown that in the context of the Gag and the Pol
proteins the RH/IN and the p68/p3 cleavage sites are processed with
similar efﬁciencies, while in vitro PR assays determined a two fold
higher Kcat for the p68/p3 cleavage site compared to RH/IN cleavage
site (Fenyöfalvi et al., 1999). This discrepancy might be due to the non-
physiological conditions of the in vitro assays. Our results proved that
in contrast to HIV the Gag and Pol maturation is not an ordered
process (Pettit et al., 1994) and the time-point of processing is not
regulated by different cleavage efﬁciencies of the PR cleavage sites
It has been shown for HIV-1 that increased or decreased
processing efﬁciencies of the PR cleavage sites directly impair
infectivity (Kozisek et al., 2012). In PFV more unprocessed Gag and
Pol seem to be tolerated. Even a 2-fold reduction of Pol cleavage
still results in approximately wild-type like infectivity (Fig. 4B–D
compare bars/lanes 1, 3, 6 and 8), but a more than 3-fold reduced
processing efﬁciency results in a decreased viral titer (Fig. 4B–D
compare lanes/bars 1, 4, 7 and 10). This tolerance could not be
attributed to higher Pol amounts in FV particles, since HIV-1 and
FV particles contain similar Gag/Pol ratios (Cartellieri et al., 2005;
Jacks et al., 1988), but it was shown that unprocessed foamy viral
Pol exhibits PR, even in the context of a Gag–Pol precursor protein,
and reduced RT activity and thus complete cleavage might be
necessary for IN function too (Hütter et al., 2013a; Spannaus et al.,
2012; Swiersy et al., 2011).
Fig. 2. Determination of FV cleavage efﬁciency of wild-type and vector system foamy viruses. (A) Schema of Gag expression constructs used in this study. (B) Western
blotting analysis of cellular lysates and concentrated viruses of PFV, and recombinant viruses produced by using different ratios of p71ΔCS and p68 expression plasmids.
Transfected amounts of p68 and p71ΔCS expression plasmids and positions of the size markers are indicated. (C) Percentage of processed Gag calculated by quantiﬁcation of
the Gag p71 and p68 bands of the cellular (gray bars) and the viral lysates (black bars) in three independent assays (p68/(p68þp71)). Quantitative Western blots were
normalized on wild-type PFV Gag maturation (85% processed Gag in the viral lysates and 82% in the cellular lysates). Error bars indicate the standard deviation of the
independent triplicate quantiﬁcations. The signiﬁcances of differences in processing compared to wild-type maturation efﬁciencies determined by the paired two-sample
t-test were marked with one (p-valueo0.05) or two asterisks (p-value o0.01) above the bars. (D) Viral titers were determined by serial dilutions. Error bars indicate the
standard deviation of three independent triplicate samples. The signiﬁcances of differences in infectivity compared to wild-type vector system determined and indicated as
described above.
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We assumed that the p68/IN hybrid cleavage site would restore
at least partially RH/IN maturation efﬁciency, but the amino acid
exchanges at position P4' (Y748R) and P3' (V749A) in the RH/IN
cleavage site resulted in an unexpected reduction of Pol cleavage
efﬁciency. Single amino acid exchanges at these positions indi-
cated an additive effect of both exchanges in suppressing protein
cleavage. In the context of the Gag protein hybrid p68/IN cleavage
site was processed with only a slightly reduced efﬁciency in the
viral lysates. These observed differences of p68/IN cleavage site
maturation in the context of Gag and Pol proteins might be
explained by the accessibility of the cleavage sites itself. Further-
more, in contrast to Pol, Gag processing inhibits the RT reaction
until sufﬁcient amounts of Gag are processed. Since the PR
requires viral RNA for dimerization, Gag processing controls
inactivation of the PR (Hartl et al., 2011; Spannaus et al., 2013).
Thus, the PR remains active until a certain threshold level of Gag
processing is reached and the PR is inactivated. This mechanism
might compensate for less efﬁcient cleavage sites. On the other
hand, in the time frame of Gag maturation sufﬁcient amounts of
Pol have to mature for optimal infectivity, since an inefﬁcient Pol
processing will not lead to prolonged PR activity.
For the viruses containing the p68/p3 cleavage site in the Pol
context a reduction of the viral titer was detected, while the
processing of Pol in the viral particles was comparable to wild-type
(Fig. 3B lanes 1 and 2, 3C and 3D corresponding bars). The effect is
similar to the Y748G substitution in P4' of the Pol PR cleavage site
(Fig. 4B–D lanes/bars 1 and 2) and the Y748R exchange (Fig. 3B lane
4, 3C and 3D corresponding bars). This leads to the conclusion that
the tyrosine in position P4’ is essential for RH or Pol function and is
supported by the observation of the Linial lab (Roy and Linial, 2007),
since amino acid substitutions to alanine of the central six amino
acids residues within the RH/IN PR cleavage site resulted in impaired
maturation and a reduction of infectivity by about two orders of
magnitude, whereas the complete exchange of all eight amino acid
residues to alanine resulted in non-infectious viral particles. We
hypostatized that as part of the C-terminal RH α-helix an exchange of
amino acid residues in this position might have impaired RH (Leo
et al., 2012a; Leo et al., 2012b).
Fig. 3. Foamy Virus Pol maturation correlates with infectivity. (A) Schema of Pol RH/IN cleavage sites used in this study. (B) Western blotting analysis of puriﬁed recombinant
viruses and cellular lysates with monoclonal anti-Gag, polyclonal anti-IN, or anti-GAPDH immune sera. Positions of the size markers are indicated. (C) Amounts of processed
Pol calculated by quantiﬁcation of the Pol and the IN bands of the cellular (gray bars) and viral lysates (black bars) in three independent assays (IN/(INþPol). Quantitative
Western blots were normalized on wild-type vector system Pol maturation (in cellular lysate 45% and in viral lysate 76%). Error bars indicate the standard deviation of the
independent triplicate quantiﬁcations. The signiﬁcances of differences in processing compared to wild-type maturation efﬁciencies determined by the paired two-sample
t-test were marked with one (p-valueo0.05) or two asterisks (p-valueo0.01) above the bars. (D) Viral titers were determined by serial dilutions. Error bars indicate the
standard deviation of three independent triplicate samples. The signiﬁcances of differences in infectivity compared to wild-type were determined by the paired two-sample
t-test and marked with one asterisk (p-value between 0.01 and 0.05) above the bars.
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The ratio of Gag p71 and Gag p68 in wild-type PFV has been
determined to be 1:4.2 (Cartellieri et al., 2005) and 1:5 in this study,
which indicates that themajority of Gag proteins have to bematurated
for viral infectivity. We found that recombinant viruses comprising of
p71ΔCS and p68 at a similar p71/p68 ratio are the most infectious.
This indicates, that small amounts of unprocessed Gag p71 are
essential for optimal infectivity. The p71 form is probably required
for an efﬁcient Gag lattice composition. The tolerance and need for
unprocessed Gag after virus maturation is in striking contrast to
Lentiviruses, where subtle changes in Gag processing resulted in a
pronounced reduction of infectivity (Müller et al., 2009). The reduction
of infectivity in comparison to wild-type FV vector system might be
due to the requirement of the p68/p3 processing for the proposed
secondary cleavage of Gag during disassembly of the virus particles
(Lehmann-Che et al., 2005) or due to partially blocked reverse
transcription by the non-cleavable Gag p71.
Recently, we have reported, that the IN domain is not required
for PR activity (Spannaus et al., 2012), whereas others described an
IN dependence (Lee et al., 2010). Here, we substantiate our
previous observation by showing that in contrast to the IN domain
the RH domain is not dispensable for PR activity. This is in-line
with results from in vitro assay systems, where the PRRT protein
exhibited PR activity only under high salt conditions and remained
inactive under physiological conditions even after the addition of
PARM (Schneider et al., 2013). This suggests a key role of the RT
and the RH domains in viral RNA dependent dimerization of the
foamy viral PR. Since viral RNA was shown to be essential for the
PR activity, we would assume that the RT domain binds speciﬁ-
cally to the RNA, whereas the RH stabilizes the PRRT-RNA complex.
In all viruses containing Pol derivatives with RT and RH domains
the protease activities were genome dependent whereas Gag
maturation in all cellular lysates was genome independent
(Figs. 5 and 6). This unspeciﬁc PR activation in cellular lysates
might be a consequence of Pol over-expression. The deletions of
the RH domain resulted in an impaired Gag maturation and the RH
domain alone (Fig. 5, PRRH) was sufﬁcient to activate PR function
genome independent with low efﬁciency probably as a result of
unspeciﬁc RNA binding by the RNase H domain. This is supported
by the observation that Gag processing efﬁciencies in viruses with
PRRTRH and genome was signiﬁcantly increased (p-valueo0.05)
compared to viruses containing only PRRH and genome suggesting
that the RT domain might promote the speciﬁc RNA dependent
activation of the viral PR, whereas the RH domain might be
required for stabilization of the complex in an RNA sequence
Fig. 4. Amino acid exchanges in the Pol cleavage site in position P2 and P2' results in impaired maturation. (A) Schema of Pol RH/IN cleavage sites used in this study.
(B) Western blotting analysis of puriﬁed recombinant viruses and cellular lysates with monoclonal anti-Gag, polyclonal anti-IN, or anti-GAPDH antibodies. In addition, to the
exchange of the Pol cleavage site a glycine-scanning was performed from the P4' to the P4 position of the Pol cleavage site. Positions of the size markers are indicated.
(C) Amounts of processed Pol calculated by quantiﬁcation of the Pol and the IN bands of the viral lysates in three independent assays (IN/(INþPol)). Quantitative Western
blots were normalized on wild-type vector system Pol maturation (76% processed Pol). Error bars indicate the standard deviation of the independent triplicate
quantiﬁcations. The signiﬁcances of differences in processing compared to wild-type maturation efﬁciencies determined by the paired two-sample t-test were marked with
one (p-value o0.05) or two asterisks (p-value o0.01) above the bars. (D) Viral titers were determined by serial dilutions. Error bars indicate the standard deviation of three
independent triplicate samples. The signiﬁcances of differences in infectivity compared to wild-type were determined by the paired two-sample t-test and marked as
described above.
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unspeciﬁc manner. This conclusion was supported by the replace-
ment of the RH domain of PRRTRH by the HIV-1 RH or the Mo-
MLV RH (Fig. 6). In comparison to PRRT containing viruses (Fig. 5)
the cleavage efﬁciencies of the Gag proteins were increased and
the PR activities were strictly genome dependent in the virus
particles. That these RH domains could partially restore the PR
activity underline that foamy viral RH-RNA interaction is not
sequence speciﬁc. The incorporation of the different Pol proteins
was always genome independent (Figs. 5 and 6, Supplementary
Table 1). Quite the opposite was observed, in the most particles the
Gag/Pol ratios were decreased up to the factor 4 without vector
genome. This might be due to the additional space insight the viral
particles allowing higher Pol incorporation. In addition, an inter-
action of foamy viral Gag and Pol proteins has been reported
before (Lee and Linial, 2008). So it seems to be possible that the
over-expression of the viral Pol proteins is sufﬁcient for a genome
independent Pol incorporation. In the cellular lysates and virus
particles containing Pol HIVRH proteins, no PRRTRH speciﬁc bands
were detected in the western blots (Fig. 6B). The full-length Pol
bands of these samples were very weak in the cellular lysates and
clearly visible only in the recombinant viruses with genome. This
indicates a full length Pol dependent PR activity, since PRRT alone
was not sufﬁcient to promote Gag processing (Fig. 5B–C).
In the viral lysates of the recombinant viruses expressing either
Pol or Pol subdomains an additional shorter PRRT form was
detected in a genome independent way (Fig. 5B). The appearance
of this protein could be due to degradation or an additional Pol
cleavage site. The existence of additional, so far unknown, cleavage
sites is further supported by experiments with a modiﬁed PFV
vector system with a PFV Pol protein encoding HIV PR instead of
the PFV PR and substitutions of the PFV cleavage site in Gag and
Pol by their HIV-1 counterparts. This system gave rise to normal
Gag (p71/p68) and Pol (PRRTRH/IN) maturation in viral particles
(data not shown), but failed to give rise to viral infectivity.
Additional PFV PR cleavage sites would help to explain this
observation.
Methods
Plasmids and transfections
For gag (previously abbreviated pcoPG4), pol (previously abbre-
viated pcoPP), and env (previously abbreviated pcoPE) expression
codon optimized plasmids were used as described before (Hartl
et al., 2011; Müllers et al., 2011; Stirnnagel et al., 2010). Gag and
Fig. 5. The RT and RH domains are required for PR activity (A) Schema of Pol expression plasmids used. (B) Western blotting analysis of puriﬁed recombinant viruses and
cellular lysates with monoclonal anti-Gag, anti-RT antibodies, or polyclonal anti-GAPDH immune serum. All Pol derivatives were analyzed in the context of the vector system
with (þ) and without () the gfp encoding vector genome pMD9. Positions of the size markers are indicated. (C) Amounts of processed Gag calculated by quantiﬁcation of
the Gag p71 and the Gag p68 bands of the viral (black bars) and the cellular lysates (gray bars) in three independent assays (p68/(p68/p71)) with (þ) and without () vector
genome. Quantitative Western blots were normalized on wild-type vector system Gag maturation (in cellular lysate 75% and in viral lysate 55%). Error bars indicate the
standard deviation of the independent triplicate quantiﬁcations. The signiﬁcances of differences in processing compared to wild-type maturation efﬁciencies (with genome)
determined by the paired two-sample t-test were marked with one (p-valueo0.05) or two black asterisks (p-valueo0.01) above the bars. The signiﬁcances of differences in
processing compared to the corresponding wild-type maturation efﬁciencies (with or without genome) were marked with one (p-valueo0.05) or two stars (p-valueo0.01)
above the bars. (D) Viral titers were determined by serial dilutions. Error bars indicate the standard deviation of three independent triplicate samples. The signiﬁcances of
differences in infectivity compared to wild-type were determined by the paired two-sample t-test and marked with one (p-valueo0.05) or two asterisks (p-valueo0.01)
above the columns.
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Pol cleavage site mutations were generated by site-directed
mutagenesis. RT, RH, and IN deletion or replacement plasmids
were constructed by PCR based cloning strategies. Proviral HIV-1
(pNL4-3 (Adachi et al., 1986)) and Mo-MLV (pcAMS (Miller and
Buttimore, 1986)) plasmids served as templates for ampliﬁcation
of the RH domain coding sequences. The RH encoding regions in
the full-length Pol as well as in the PRRTRH expression plasmids
were substituted by the HIV-1 and the Mo-MLV RH domain
encoding DNA fragments (Fig. 6A). All constructs were veriﬁed
by nucleotide sequencing. To generate recombinant viruses HEK
293 T cells (1, 8106) were transfected with the codon optimized
expression plasmids for gag (3 mg), pol (0.12 mg Figs. 1, 2 and 4 and
1.2 mg Figs. 3, 5 and 6), env (1.2 mg), and the gfp encoding vector
genome pMD9 (6 mg) (Heinkelein et al., 2002) using PEI as
described before (Spannaus et al., 2013). Three days after transfec-
tion cells were lysed with RIPA buffer (150 mM NaCl, 1% NP40,
0.5% deoxycholate, 0.1% SDS, 50 mM Tris pH 8) and analyzed for
Gag and Pol processing by Western blotting.
Virus puriﬁcation and infectivity assays
The supernatant of 1, 8106 HEK 293 T cells was ﬁlter sterili-
zed. The supernatant was partially puriﬁed by size exclusion
chromatography using HiTrap Capto Core 700 columns (GE Health-
care, Germany) and sodium phosphate buffer (20 mM, pH 7) as
running buffer to exclude non-particle associated proteins. Viruses
were concentrated by ultra-centrifugation (201,149g, 4 1C, 2 h) as
described before (Hartl et al., 2011). Viral proteins were visualized by
Western blotting. To determine viral infectivity cell culture super-
natants were titrated on BHK-21 cells in triplicate assays. GFP positive
cell after titration of supernatants from non-transfected cells were not
observed. The number of GFP expressing cells was counted after two
days using a ﬂuorescence microscope. Viral titers were subsequently
determined in at least three biologically independent experiments in
triplicates and standard deviations were calculated. The signiﬁcances
of titer alterations were calculated by the paired two-sample t-test.
Signiﬁcant differences in comparison to the wild-type vector system
were indicated with one (p-value o0.05) or two asterisks (p-value
o0.01) above the columns. PFV was co-cultivated in BHK-21 cells as
previously described for HIV-1 (Cígler et al., 2005). PFV containing
supernatants were ﬁltered (0.45 mm) and viruses were concentrated
by ultra-centrifugation as described before (Hartl et al., 2011). Viruses
were further puriﬁed by iodixanol gradient (9%, 6–35% iodixanol in
PBS) centrifugation (172,647g, 4 1C, 1.5 h) as described before for HIV-1
(Dettenhofer and Yu, 1999). Virus containing fractions (19–25% iodix-
anol) were diluted in PBS (1:5) and concentrated by ultra-
centrifugation (198,835g 4 1C, 1 h).
Fig. 6. Mo-MLV and HIV-1 RH domains support PR function. (A) Schema of Pol expression plasmids used. (B) Western blotting analysis of puriﬁed recombinant viruses and
cellular lysates with monoclonal anti-Gag, anti-RT antibodies, or polyclonal anti-GAPDH immune serum. All Pol derivatives were analyzed in the context of the vector system
with (þ) and without () the gfp encoding vector genome pMD9. Positions of the size markers are indicated. (C) Amounts of processed Gag calculated by quantiﬁcation of
the Gag p71 and the Gag p68 bands of the viral (black bars) and the cellular lysates (gray bars) in three independent assays (p68/(p68/p71)) with (þ) and without () vector
genome. Quantitative Western blots were normalized on wild-type vector system Gag maturation (in cellular lysate 74% and in viral lysate 55%). Error bars indicate the
standard deviation of the independent triplicate quantiﬁcations. The signiﬁcances of differences in processing compared to wild-type maturation efﬁciencies (with genome)
determined by the paired two-sample t-test were marked with one (p-valueo0.05) or two asterisks (p-valueo0.01) above the bars. The signiﬁcances of differences in
processing compared to the corresponding wild-type maturation efﬁciencies (with or without genome) were marked with one (p-valueo0.05) or two stars (p-valueo0.01)
above the bars. (D) Viral titers were determined by serial dilutions. Error bars indicate the standard deviation of three independent triplicate samples. The signiﬁcances of
differences in infectivity compared to wild-type were determined by the paired two-sample t-test and indicated as described above.
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Western blotting
Gag and Pol were detected using monoclonal antibodies
against Gag (SGG1) (Heinkelein et al., 2002) and RT (15E10)
(Imrich et al., 2000) and a polyclonal antiserum against the IN
domain (Pahl and Flügel, 1995). GAPDH amounts were visualized
using an anti-GAPDH serum (Sigma-Aldrich). All Western blotting
analyses in this report (Figs. 1–6) are representative for all
experiments done. Relative Gag and Pol amounts were quantiﬁed
from three biologically independent Western blotting analyses
using AIDA software package (GE Healthcare) (Spannaus et al.,
2013). The signiﬁcances of differences in processing compared to
wild-type maturation efﬁciencies were determined by the paired
two-sample t-test and were marked with one (p-value o0.05) or
two black asterisks (p-value o0.01) above the columns (Figs. 1–6).
Further, the signiﬁcances of differences in processing compared to
corresponding wild-type maturation efﬁciencies (with or without
genome) were determined by the paired two-sample t-test and
were marked with one (p-value o0.05) or two stars (p-value
o0.01) above the columns (Figs. 5 and 6).
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